Domov › Prekomerna telesna teža › Florida › Orlando
Klinične študije za Prekomerna telesna teža v Orlando, FL
27 študij za Prekomerna telesna teža išče udeležence na lokacijah v Orlando in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Vključevanje udeležencevFaza 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Vključevanje udeležencev
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
- Kailera Clinical Site, Orlando
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Vključevanje udeležencevFaza 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Vključevanje udeležencevFaza 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · 5 mi stran
- K2 Medical Research Maitland LLC, Main Office, Maitland · 6 mi stran
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Vključevanje udeležencevFaza 2
- Clinical Neuroscience Solutions, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Vključevanje udeležencevFaza 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Vključevanje udeležencevFaza 3
- Florida Inst For Clin Res LLC, Orlando
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Vključevanje udeležencevFaza 3
- Headlands Research Orlando, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Vključevanje udeležencevFaza 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Vključevanje udeležencevFaza 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Vključevanje udeležencevFaza 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Vključevanje udeležencevFaza 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi stran
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Vključevanje udeležencevFaza 3
- Research Site, Ocoee · 10 mi stran
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Vključevanje udeležencevFaza 3
- West Orange Endocrinology, Ocoee · 10 mi stran
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Vključevanje udeležencevFaza 3
- Conquest Research, Winter Park · 5 mi stran
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Vključevanje udeležencevFaza 2
- Charter Research - Winter Park, Orlando
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Vključevanje udeležencevFaza 3
- AURORA-1 Clinical Site, Winter Park · 5 mi stran
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Vključevanje udeležencevFaza 3
- AURORA-2 Clinical Site, Winter Park · 5 mi stran
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Vključevanje udeležencev
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
- ACCOMPLISH-2 Research Site, Ocoee · 10 mi stran
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Vključevanje udeležencevFaza 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Vključevanje udeležencevFaza 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Vključevanje udeležencevFaza 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Vključevanje udeležencevFaza 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · 5 mi stran
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Vključevanje udeležencevFaza 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Vključevanje udeležencevFaza 3
- ACCOMPLISH-1 Research Site, Ocoee · 10 mi stran
Študije za Prekomerna telesna teža v drugih mestih
- San Antonio, TX34 študij
- Houston, TX33 študij
- Chicago, IL28 študij
- Las Vegas, NV23 študij
- Miami, FL23 študij
- Atlanta, GA20 študij
- Dallas, TX20 študij
- New York City, NY19 študij
- Jacksonville, FL19 študij
- Washington, DC19 študij
- Austin, TX18 študij
- Baltimore, MD17 študij
Druge študije v Orlando
- Nemalicelični pljučni rak44 študij
- Debelost31 študij
- Metastatski rak29 študij
- Alzheimerjeva bolezen25 študij
- Sladkorna bolezen tipa 224 študij
- Rak (vse vrste)24 študij
- Rak dojke23 študij
- Rak jajčnikov22 študij
- Ulcerativni kolitis22 študij
- Rak pljuč21 študij
- Kolorektalni rak19 študij
- Velika depresivna motnja19 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.